Comparing Efficacy of 8-Week and 12-Week Faricimab Initial Follow-Up Treatment Intervals

NCT06875245 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

100

Enrollment

OTHER_GOV

Sponsor class

Conditions

Wet Age-related Macular Degeneration

Interventions

DRUG: Faricimab Injection

Sponsor

Faculty Hospital Kralovske Vinohrady